Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
2.85Price to Sales
VS
Market
Sector
Industry
History
$ 5.87Close
$ 5.02 - $ 21.59 52-Week Range
Ticker Information
Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQENTRADA THERAPEUTICS INC - Price to Sales Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
TRDA - P/S Historical data
| Date | Market Capitalization | Price to Sales | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 226.32M | 2.85 | $ 79.48M |
| 3/31/2025 | $ 327.16M | 1.9 | $ 172.22M |
| 12/31/2024 | $ 450.38M | 2.14 | $ 210.78M |
| 9/30/2024 | $ 696.76M | 3.24 | $ 215.23M |
| 6/30/2024 | $ 588.12M | 2.46 | $ 239.4M |
| 3/31/2024 | $ 468.57M | 2.88 | $ 162.87M |
| 12/31/2023 | $ 427.07M | 3.31 | $ 129.01M |
| 9/30/2023 | $ 566.92M | 6.5 | $ 87.17M |
| 6/30/2023 | $ 512.38M | 11.8 | $ 43.43M |
| 3/31/2023 | $ 396.04M | 15.68 | $ 25.26M |
Key Performance Insights, Last 5 Years
- ENTRADA THERAPEUTICS INC's latest trailing twelve months (TTM) P/S stands at 0.
- Over the past 5 years, ENTRADA THERAPEUTICS INC's average P/S has been 5.27.
- The median P/S for ENTRADA THERAPEUTICS INC during this period was 3.06
- ENTRADA THERAPEUTICS INC reached its highest P/S over the past 5 years at 15.68.
- The lowest P/S recorded by ENTRADA THERAPEUTICS INC in the same timeframe 1.9
ENTRADA THERAPEUTICS INC's P/S vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
P/S Benchmarks
Similar metrics to Revenues:
- Price to Free Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Free Cash Flow [FCF].
- Price to Operating Cash Flow - [Calculation] Measures a company’s [MarketCap] in relation to its Operating Cash Flow [NCFO].
- Price to Book - [Calculation] Measures a company’s [MarketCap] in relation to its [Equity] which is the value of [Assets] minus [Liabilities].
- Enterprise Value over Free Cash Flow - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its Free Cash Flow [FCF].
- Free Cash Flow Yield - [Calculation] The Free Cash Flow Yield, also known as the inverse of the Price to Free Cash Flow ratio [PFCF], expresses a company’s Free Cash Flow [FCF] as a percentage of [MarketCap.
Definition of Price to Sales
[Calculation] Measures a company’s [MarketCap] in relation to its [Revenue].Market Cap / Revenues
(=) P/S P/S for ENTRADA THERAPEUTICS INC is calculated as follows: Market Cap [ $ 0 ] / Revenues [ $ 0 ]
(=) P/S [ 0 ] TRDA - Price to Sales, Last 5 years
1.9
Minimum
Mar 31, 2025
15.68
Maximum
Mar 31, 2023
5.27
Average
3.06
Median
P/S Benchmark AnalysisMarket
The chart above depicts the distribution of P/S for companies in the Total Stock Market. The average P/S of the companies is 2.62 with a standard deviation of 2.38.
The following table provides additional summary stats:
P/S in the Market:
| filtered constituents | 3.42K |
|---|---|
| min | 0 |
| max | 11.15 |
| average | 2.62 |
| median | 1.97 |
| std | 2.38 |